Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polio vaccine mucosal immunity trial in children in Pakistan
ACTRN12612000264886Phase 4Recruiting
- Sponsor
- World Health Organization
- Start
- Mar 2012
- Modality
- Small Molecules, Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of bivalent oral poliovirus vaccine, trivalent inactivated polio vaccine and vitamin a in poliomyelitis (5 arms), sponsored by World Health Organization. Primary endpoint: Reduction in excretion of challenge vaccine poliovirus. Started Mar 2012; status: recruiting.
02
Drugs
bivalent oral poliovirus vaccinetrivalent inactivated polio vaccinevitamin a
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on ACTRN12612000264886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000264886.